Study of DF1001 in Patients With Advanced Solid Tumors
Phase 1/2 Completed
270 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
FEGALA
Phase NA Completed
411 enrolled
PREPARE
Phase NA Completed
792 enrolled
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
KANSURVIVE
Phase NA Completed
15 enrolled 18 charts
CONFIGURE
Phase NA Completed
41 enrolled 6 charts
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Phase 1 Completed
40 enrolled
IMPLICATION
Completed
167 enrolled
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Phase 1 Completed
168 enrolled
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1/2 Completed
43 enrolled 15 charts
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Phase 1 Completed
53 enrolled
INOVOLINE
Phase NA Completed
101 enrolled
NAVIGATE
Phase 2 Completed
215 enrolled 3 FDA
CALM: Managing Distress in Malignant Brain Cancer
Phase NA Completed
60 enrolled
ENGAGE
Phase NA Completed
292 enrolled
Study of ESG401 in Adults With Solid Tumors
Phase 1/2 Completed
156 enrolled
SBRT
Completed
98 enrolled
EARN
Phase NA Completed
33 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
Study to Evaluate CCS1477 in Advanced Tumours
Phase 1/2 Completed
220 enrolled
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
PRIORITY
Completed
346 enrolled 9 charts
EXODIAG
Phase NA Completed
71 enrolled
Cytological Examination of Malignant Pleural Effusion in Breast Cancer
Completed
50 enrolled
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
Phase 1 Completed
17 enrolled
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
Phase 1 Completed
17 enrolled 8 charts
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
Phase 1 Completed
64 enrolled
A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.
Phase 2 Completed
90 enrolled
VOICE
Phase NA Completed
1,007 enrolled
PREFER
Completed
1,429 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
MOM
Completed
40 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
K-DETEK
Completed
9,057 enrolled
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Phase NA Completed
40 enrolled
CARMA
Phase NA Completed
20 enrolled
Improving Evidence-Based Care for Cancer Patients
Completed
128 enrolled
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Phase 1 Completed
112 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Phase 1/2 Completed
323 enrolled
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Phase 1 Completed
121 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Dendritic Cell Vaccination for Patients with Solid Tumors
Phase 1/2 Completed
48 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Phase 1 Completed
279 enrolled